CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in HIMS — Hims & Hers Health, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in HIMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$48,966,902
-$28,896,417 QoQ
Shares Held
2,358,714
-1.6% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. HIMS ranks #9 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,717,247 | $439,415,767 | |
| 2 | VTRS |
Viatris Inc
|
13,674,306 | $184,739,874 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
300,481 | $178,179,223 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
902,788 | $118,933,291 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,577,850 | $85,617,950 | |
| 6 | ALKS |
Alkermes plc.
|
2,236,756 | $79,091,692 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,087,679 | $62,880,891 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
657,413 | $49,864,776 |
All Filings in HIMS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,966,902 | 2,358,714 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $77,863,319 | 2,398,008 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $133,600,500 | 2,355,439 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $80,243,445 | 1,609,698 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $47,634,481 | 1,611,996 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $43,447,542 | 1,796,838 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $30,713,913 | 1,667,422 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $29,252,402 | 1,448,856 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $18,976,801 | 1,226,684 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $11,523,355 | 1,294,759 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,005,597 | 1,272,750 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,602,504 | 915,160 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,932,682 | 900,472 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,816,184 | 907,361 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,902,571 | 878,597 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,945,738 | 871,024 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,284,420 | 616,214 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,938,017 | 601,224 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,425,957 | 586,997 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,435,206 | 315,446 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,069,534 | 307,599 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||